Bioactive Compounds in Watermelon Modulating Oxidative Stress and Inflammation in Elders
MOXIE
1 other identifier
interventional
21
0 countries
N/A
Brief Summary
Watermelon is the only food with a unique combination of amino acids and antioxidants that may reduce artery stiffness. However, only 27% of older adults meet the daily recommendation for fruit intake. Because it tastes good and is convenient and easy to consume, watermelon juice is an innovative and impactful intervention to help elders easily meet recommendations for fruit servings. If effective, this intervention would be a simple, inexpensive way to combat cardiovascular diseases (CVD). Results will advance science by providing a better understanding whether four-week consumption of 100% watermelon juice may impact measures of vascular health and inflammation in postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2018
CompletedFirst Submitted
Initial submission to the registry
July 24, 2018
CompletedFirst Posted
Study publicly available on registry
August 10, 2018
CompletedResults Posted
Study results publicly available
May 17, 2022
CompletedMay 17, 2022
May 1, 2022
2.2 years
July 24, 2018
September 9, 2021
May 16, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Change From Baseline in Serum Levels of Lycopene at 4 Weeks
Lycopene determined by ultra high performance liquid chromatography with photodiode array detector (UPLC-PDA).
Baseline and 4 Weeks
Change in Vascular Endothelial Function at 4 Weeks
Determined by brachial artery flow-mediated dilation (FMD). FMD uses ultrasound technology to quantify changes in brachial artery diameter in response to hyperemia. A blood pressure cuff was placed distal to the brachial artery of the right arm with the participant supine and rested. Pre-inflation diameter was recorded for one minute, and the cuff was inflated to 50 mmHg above resting SBP for five minutes. Then, images were recorded for 120 seconds after cuff deflation. Peak diameter was determined as an average of the five highest measurements over five seconds post-deflation. FMD was expressed as the percentage increase in peak diameter.
Baseline and 4 weeks
Change in Arterial Stiffness at 4 Weeks
Determined by pulse wave velocity (PWV). A cuff-based system was used to measure brachial oscillometric pressure waveforms and generate central pressure curves by propriety algorithms. PWV was quantified as the rate at which a pulse wave moves down a vessel.
Baseline and 4 weeks
Study Arms (2)
Consumption of 100% watermelon juice
ACTIVE COMPARATORConsumption of two 12-ounce doses of pasteurized 100% watermelon juice for a four-week period
Consumption of a placebo beverage
PLACEBO COMPARATORConsumption of a placebo beverage with comparable sugar content, pH, taste, texture, and color for a four-week period
Interventions
Participants drank two 12-ounce servings of 100% watermelon juice per day for a four-week period.
Participants drank two 12-ounce servings of a placebo beverage per day for a four-week period.
Eligibility Criteria
You may qualify if:
- Ambulatory
- Female
- Age 55-69 years
- Body mass index 18.5 - 29.9 kg/m2 (non-obese)
You may not qualify if:
- Food allergy to watermelon
- History of hypotension, chronic hypertension, chronic kidney disease, diabetes, previous cardiac events or procedures, phenylketonuria
- Smoking or other tobacco use
- Use of anticoagulant medications, cholesterol-lowering medications, blood-pressure medications, vasodilatory dietary supplements (garlic, fish oil), or dietary supplements containing lycopene, ascorbic acid, L-glutamine, L-arginine, or L-citrulline
- Weight change \> 10% in the previous year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Ellis AC, Dudenbostel T, Locher JL, Crowe-White K. Modulating Oxidative Stress and Inflammation in Elders: The MOXIE Study. J Nutr Gerontol Geriatr. 2016 Oct-Dec;35(4):219-242. doi: 10.1080/21551197.2016.1250693.
PMID: 27897608BACKGROUNDEllis AC, Mehta T, Nagabooshanam VA, Dudenbostel T, Locher JL, Crowe-White KM. Daily 100% watermelon juice consumption and vascular function among postmenopausal women: A randomized controlled trial. Nutr Metab Cardiovasc Dis. 2021 Sep 22;31(10):2959-2968. doi: 10.1016/j.numecd.2021.06.022. Epub 2021 Jul 7.
PMID: 34344546DERIVEDCrowe-White KM, Voruganti VS, Talevi V, Dudenbostel T, Nagabooshanam VA, Locher JL, Ellis AC. Variation of Serum Lycopene in Response to 100% Watermelon Juice: An Exploratory Analysis of Genetic Variants in a Randomized Controlled Crossover Study. Curr Dev Nutr. 2020 Jun 17;4(7):nzaa102. doi: 10.1093/cdn/nzaa102. eCollection 2020 Jul.
PMID: 32695957DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Amy Ellis, principal investigator
- Organization
- The University of Alabama
Study Officials
- PRINCIPAL INVESTIGATOR
Amy C Ellis, PhD, RD
University of Alabama at Birmingham
- PRINCIPAL INVESTIGATOR
Kristi Crowe-White, PhD, RD
University of Alabama at Birmingham
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- In this crossover design, the participants principal investigators, and outcomes assessors were blinded as to which treatment (100% watermelon juice or placebo) was consumed at each time.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 24, 2018
First Posted
August 10, 2018
Study Start
February 16, 2016
Primary Completion
May 12, 2018
Study Completion
May 12, 2018
Last Updated
May 17, 2022
Results First Posted
May 17, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share